Sufficient trial size to inform clinical practice
暂无分享,去创建一个
[1] D J Reda,et al. Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .
[2] D. Berry,et al. Choosing sample size for a clinical trial using decision analysis , 2003 .
[3] Richard J. Cook,et al. Multiplicity Considerations in the Design and Analysis of Clinical Trials , 1996 .
[4] A. Hrõbjartsson,et al. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.
[5] N. Lazar,et al. The ASA Statement on p-Values: Context, Process, and Purpose , 2016 .
[6] P. Sedgwick. Clinical significance versus statistical significance , 2014, BMJ : British Medical Journal.
[7] Anthony C. Atkinson,et al. Optimum Experimental Designs, with SAS , 2007 .
[8] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[9] Abraham Wald,et al. Statistical Decision Functions , 1951 .
[10] C. Manski. Statistical treatment rules for heterogeneous populations , 2003 .
[11] Gábor Lugosi,et al. Pattern Classification and Learning Theory , 2002 .
[12] D. Berry. Bayesian Statistics and the Efficiency and Ethics of Clinical Trials , 2004 .
[13] K. Schlag. ELEVEN - Tests needed for a Recommendation , 2006 .
[14] Charles F. Manski,et al. Minimax-regret treatment choice with missing outcome data , 2007 .
[15] D. Ellsberg. Decision, probability, and utility: Risk, ambiguity, and the Savage axioms , 1961 .
[16] D. Spiegelhalter. Incorporating Bayesian Ideas into Health-Care Evaluation , 2004 .
[17] Gerald S. Rogers,et al. Mathematical Statistics: A Decision Theoretic Approach , 1967 .
[18] D. Altman. Statistics and ethics in medical research: III How large a sample? , 1980, British medical journal.
[19] A. Tetenov. Statistical treatment choice based on asymmetric minimax regret criteria , 2009 .
[20] David J. Spiegelhalter,et al. Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.
[21] J. Karlawish,et al. The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.
[22] K Claxton,et al. An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.
[23] Jörg Stoye,et al. Minimax regret treatment choice with finite samples , 2009 .
[24] W. Hoeffding. Probability Inequalities for sums of Bounded Random Variables , 1963 .
[25] Jörg Stoye. Minimax regret treatment choice with covariates or with limited validity of experiments , 2012 .
[26] C. Manski,et al. Admissible treatment rules for a risk-averse planner with experimental data on an innovation , 2007 .
[27] J. Berger. Statistical Decision Theory and Bayesian Analysis , 1988 .
[28] Stephen B. Vardeman,et al. Statistics and Ethics , 2003 .
[29] V. Bentkus. On Hoeffding’s inequalities , 2004, math/0410159.
[30] J. Fleiss. Statistical methods for rates and proportions , 1974 .
[31] D Meltzer,et al. Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. , 2001, Journal of health economics.
[32] Leonard J. Savage,et al. The Theory of Statistical Decision , 1951 .
[33] B. Everitt,et al. Statistical methods for rates and proportions , 1973 .
[34] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[35] Ben Alamar. Social Choice With Partial Knowledge of Treatment Response , 2007 .
[36] K. Hirano,et al. Asymptotics for Statistical Treatment Rules , 2009 .
[37] Canada,et al. STATISTICAL METHODS FOR , 2004 .
[38] P. Lichtenberg,et al. The ethics of the placebo in clinical practice , 2004, Journal of Medical Ethics.
[39] N. Fisher,et al. Probability Inequalities for Sums of Bounded Random Variables , 1994 .